Copper (II) complex 1 is a metal-based PDI inhibitor and exhibits antitumor activity in various cancer cells in vitro (2008, BxPC3, PSN1, HCT-15, BCPAP, and A375) and in vivo (LLC) [124]. This evidence concerns the gene NT5C3A and cancer.